BioLineRx to Report Third Quarter 2025 Results on November 24, 2025

Go back to BioLineRx to Report Third Quarter 2025 Results on November 24, 2025
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.76 -0.17 (5.8%)
Previous Close $2.93    52 Week High $1.63 
Open $2.96    52 Week Low $0.71 
Day High $3.00    P/E N/A 
Day Low $2.76    EPS $0.00 
Volume 4,270       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.76 -0.17 (5.8%)
Previous Close $2.93    52 Week High $1.63 
Open $2.96    52 Week Low $0.71 
Day High $3.00    P/E N/A 
Day Low $2.76    EPS $0.00 
Volume 4,270